TB drugs- Allman Flashcards
define multidrug-resistant (MDR) TB
- resistant to at lead INH AND RIF
what are MDR patients at high risk for
-treatment failure and further acquired drug resistance
what happens to patients with just strain resistant to RIFAMPIN alone
- better prognosis
- increase risk for treatment failure
What is extensive drug Resistant (XDR) TB
- MDR TB plus resistance to FQN
- AND resistant to at least one other of the 3 injectable drugs
- amikacin
- kanamycin
- capreomycin
what defines therapeutic failure
positive sputum coherent scattering after 4 months of compliant therapy
what is the dosing guideline for TB drugs
- daily dosing
- twice or thrice weekly dosing
- Directly observed therapy
MOA for Rifampin
inhibits DNA-dependent RNA polymerase
- suppression of initiation of chain formation in RNA synthesis
Bactericidal: kills slow-growing mycobacteria present within macrophages and in caseating granulomas
where is Rifampin distributed
CNS
tuberculosis abscesses
intracellular sites
How is Rifampin metabolized
deacetylation
- autoinductin of metabolism occurs
- Rifampin Revs up Liver
3 major adverse effects of Rifampin
- transient elevation in serum transaminases
- hepatotoxicity
- orange discoloration ( sweat, tears, urine)
- Rifampin revs up and red
Drug interaction of Rifampin
- increase in cytochrome P-459
- increases metabolism of
- warfarin
- narcotics
- steroids ( oral contraceptives)
place in therapy: Rifampin
- treats active TB
- 2nd line agent for preventative therapy
MOA for Isoniazid ( INH)
inhibits synthesis of mycolic acid
metabolism of Isoniazid
acetylation
Rate of acetylation of Isoniazid depend son what
genes: can be slow or rapid acetylator
Adverse effects of Isoniazid
- transient elevation in serum transaminases
- hepatotoxicity
- Neurotoxicity
who is neurotoxicity seen in with Isoniazid, treatment?
- alcoholics, homeless
- Pyridoxine ( B6)
MOA for Pyrazinamide
- not well known
- toward dormant organism
Adverse effects of Pyrazinamide
Hepatotoxicity
hyperuricemia : decreased renal excretion of uric acid, bad for gout patients
MOA for Ethambutol
not well known
bacteriostatic